| __timestamp | Perrigo Company plc | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 2242216 |
| Thursday, January 1, 2015 | 187800000 | 4536244 |
| Friday, January 1, 2016 | 184000000 | 5184803 |
| Sunday, January 1, 2017 | 167700000 | 3068742 |
| Monday, January 1, 2018 | 218600000 | 7178000 |
| Tuesday, January 1, 2019 | 187400000 | 16267000 |
| Wednesday, January 1, 2020 | 177700000 | 23191000 |
| Friday, January 1, 2021 | 122000000 | 21453000 |
| Saturday, January 1, 2022 | 123100000 | 15265000 |
| Sunday, January 1, 2023 | 122500000 | 25189000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Perrigo Company plc and Soleno Therapeutics, Inc. have demonstrated contrasting R&D investment strategies.
Perrigo, a global leader in over-the-counter health products, has consistently allocated substantial resources to R&D, with expenses peaking in 2018. Despite a 44% decrease in spending from 2018 to 2023, Perrigo's average annual R&D investment remains robust, reflecting its strategic focus on product development.
Conversely, Soleno Therapeutics, a niche player in rare disease treatments, has shown a remarkable upward trend in R&D spending. From 2014 to 2023, Soleno's R&D expenses surged by over 1,000%, underscoring its aggressive pursuit of innovative therapies. This divergence in R&D strategies highlights the varied approaches companies take to drive growth and maintain competitive advantage in the pharmaceutical sector.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Perrigo Company plc
R&D Insights: How Zoetis Inc. and Soleno Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: GSK plc and Perrigo Company plc
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Perrigo Company plc
Biogen Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Perrigo Company plc
Research and Development: Comparing Key Metrics for Opthea Limited and Soleno Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. or Perrigo Company plc: Who Invests More in Innovation?
Rhythm Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Perrigo Company plc vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Catalyst Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.